BackCelyad Oncology Overview

Celyad Oncology Selling, General & Admin

Selling, General & Admin expenses for CYAD.

Quarterly SG&A Expenses

$1.46M
↓ 43.48% YoY

As of Dec 31, 2024

Annual SG&A Expenses (TTM)

$9.42M
↓ 10.7% YoY

Trailing 12 months ending Dec 31, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin